Drugs / TSD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02189083 | May 2014 → Nov 2015 | leiomyoma | The University of Hong Kong | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TSD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02189083 ↗ |
| Action | Inhibit | “TSD robustly inhibits fibroid cell growth and proliferation.” NCT02189083 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “TSD, a Chinese Medicine Preparation” NCT02189083 ↗ |
| Route | Oral | “Orally in-take one bag of TSD decoction in morning and another in evening after meal” NCT02189083 ↗ |